Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Greinacher

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
Annals of Hematology|September 1, 2001
Perioperative management of a patient with Fechtner syndromeA C Matzdorff, J G White, K Malzahn, et al.
Thrombosis and Haemostasis|January 12, 2001
Heparin-platelet factor (PF) 4 antibodies in patients with pseudothrombocytopenia: coincidence or association?I Schwarzinger, W Speiser, N Lubenow, et al.
Vox Sanguinis|June 6, 2002
Acute haemolytic transfusion reactions due to weak antibodies that in vitro did not seem to be clinically significantB Hoppe, L Pastucha, A Seltsam, et al.
Blood|May 26, 1999
The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patientsL E Carlsson, S Santoso, C Spitzer, et al.
British Journal of Anaesthesia|August 18, 2006
Disseminated intravascular clotting associated with Fc-receptor IIa-mediated platelet activation in a patient with endocarditis after aortic valve replacementE Kottenberg-Assenmacher, L Volbracht, H Jakob, et al.
Thrombosis and Haemostasis|September 1, 1995
Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopeniaA Greinacher, S Alban, V Dummel, et al.
Journal of Thrombosis and Haemostasis : JTH|January 7, 2010
Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunizationT E Warkentin, R J Cook, V J Marder, et al.
Stroke|July 1, 1997
Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for strokeL E Carlsson, A Greinacher, C Spitzer, et al.
British Journal of Haematology|August 1, 1993
Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharidesA Greinacher, I Michels, U Liebenhoff, et al.
Der Internist|March 8, 2017
[Recurrent thromboembolisms despite full anticoagulation in a patient with antiphospholipid syndrome]S Wernicke, K Selleng, S B Felix, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Annals of Hematology|September 1, 2001
Perioperative management of a patient with Fechtner syndromeA C Matzdorff, J G White, K Malzahn, et al.
Thrombosis and Haemostasis|January 12, 2001
Heparin-platelet factor (PF) 4 antibodies in patients with pseudothrombocytopenia: coincidence or association?I Schwarzinger, W Speiser, N Lubenow, et al.
Vox Sanguinis|June 6, 2002
Acute haemolytic transfusion reactions due to weak antibodies that in vitro did not seem to be clinically significantB Hoppe, L Pastucha, A Seltsam, et al.
Blood|May 26, 1999
The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2beta1 might be a genetic risk factor for the development of stroke in younger patientsL E Carlsson, S Santoso, C Spitzer, et al.
British Journal of Anaesthesia|August 18, 2006
Disseminated intravascular clotting associated with Fc-receptor IIa-mediated platelet activation in a patient with endocarditis after aortic valve replacementE Kottenberg-Assenmacher, L Volbracht, H Jakob, et al.
Thrombosis and Haemostasis|September 1, 1995
Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopeniaA Greinacher, S Alban, V Dummel, et al.
Journal of Thrombosis and Haemostasis : JTH|January 7, 2010
Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunizationT E Warkentin, R J Cook, V J Marder, et al.
Stroke|July 1, 1997
Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for strokeL E Carlsson, A Greinacher, C Spitzer, et al.
British Journal of Haematology|August 1, 1993
Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharidesA Greinacher, I Michels, U Liebenhoff, et al.
Der Internist|March 8, 2017
[Recurrent thromboembolisms despite full anticoagulation in a patient with antiphospholipid syndrome]S Wernicke, K Selleng, S B Felix, et al.
Pageof 17